Sharon Elizabeth Tetlow
Independent DirectorMs. Sharon Elizabeth Tetlow is Independent Director of Structure Therapeutics Inc. from March 2022. Ms. Tetlow serves as Director at Cessation Therapeutics, LLC. Ms. Tetlow has served as Managing Partner of Potrero Hill Advisors since January 2016. Potrero Hill Advisors provides strategic and operational financial support to life science companies through its team of chief financial officers and controllers. Ms. Tetlow was previously the Managing Director of Danforth Advisors from April 2013 to January 2016. She served as Chief Financial Officer of Pathwork Diagnostics, Inc, a privately held biotechnology company, from 2011 to 2013. From 2005 to 2009, she served as Chief Financial Officer of Cell Genesys, Inc.(CEGE) a publicly traded biotechnology company. In connection with her role as managing partner of Potrero Hill Advisors, Ms. Tetlow has led the finance function at several biotechnology and pharmaceutical companies, including 4D Molecular Therapeutics Inc and Ocera Therapeutics, Inc., two privately held companies and Allakos, Inc. and CytomX, Inc., two publicly traded companies. Ms. Tetlow was previously on the Board of Directors of Armetheon, Inc, a privately held company. Ms. Tetlow currently serves on the Board of Catalyst Biosciences (NASDAQ: CBIO). Ms. Tetlow holds a Bachelor of Arts Degree in Psychology from the University of Delaware and a Masters degree in Business from the Stanford University Graduate School of Business.
公司职务
- 公司名称Structure Therapeutics Inc.股票代码GPCR职务Independent Director共事同僚
- RCRaymond C. StevensCEO & Director
- DGDaniel G. WelchIndependent Chairman
- JSJun S. YoonCo- Founder, CFO & Secretary
- YMYingli MaChief Technology Officer
- XLXichen LinChief Scientific Officer & GM of Structure Shanghai
- BCBlai CollChief Medical Officer
- TWTed W. LoveIndependent Director
- ELEric L. DobmeierIndependent Director
